SK biopharmaceuticals Co., Ltd. Logo

SK biopharmaceuticals Co., Ltd.

Develops and commercializes CNS and oncology therapies for global markets, focusing on the U.S.

326030 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교역로 221, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

SK Biopharmaceuticals is a global, fully integrated pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies. The company's primary therapeutic area is central nervous system (CNS) disorders, with an expanding pipeline in oncology. Its business model encompasses the entire value chain, from research and development to direct commercialization in key global markets, particularly the United States. The company's flagship product is cenobamate (marketed as XCOPRI® in the U.S.), an anti-seizure medication that has demonstrated significant commercial growth. SK Biopharmaceuticals actively incorporates advanced technologies, including artificial intelligence, to accelerate its drug development process and address unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Regulatory News Service
투자판단관련주요경영사항
Korean 12.8 KB
2025-08-29 00:00
Regulatory News Service
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 5.9 KB
2025-08-14 00:00
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 2.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 4.6 MB
2025-08-05 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.7 KB
2025-07-30 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.0 KB
2025-07-29 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 8.3 KB
2025-06-24 00:00
Regulatory News Service
단일판매ㆍ공급계약체결
Korean 8.3 KB
2025-06-20 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 8.0 KB
2025-06-18 00:00
M&A Activity
[기재정정]투자판단관련주요경영사항
Korean 16.7 KB
2025-06-02 00:00
Governance Information
기업지배구조보고서공시
Korean 2.2 MB
2025-05-30 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 148.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 2.2 MB
2025-05-09 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.7 KB
2025-05-02 00:00
Report Publication Announcement
기업설명회(IR)개최(안내공시)
Korean 6.0 KB

Automate Your Workflow. Get a real-time feed of all SK biopharmaceuticals Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SK biopharmaceuticals Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.